DEALS
Zhong Lun Law Firm Assisted SoftBank Vision Fund II in Successfully Investing in EDDA Technology
Zhong Lun Law Firm Assisted SoftBank Vision Fund II in Successfully Investing in EDDA Technology
According to the announcement published by Softbank Capital (SBCVC), on April 7, 2021, EDDA Technology, the pioneer of intelligent surgical robots and intelligent robotic solutions for precision surgery, announced the closing of financing of USD 150 million, which was led by SoftBank Vision Fund II and co-invested by well-known medical industry fund OrbiMed, 3W Fund. The company’s existing investors include many well-known funds such as Morningside Ventures, Matrix Partners China, SBCVC, BOCGI, Trust Bridge, and Draper Dragon, etc.
Zhong Lun Law Firm, as the PRC legal counsel of SoftBank Vision Fund II, provided legal support to SoftBank Vision Fund II for its investment in EDDA Technology. The hosting partner of this project is Audry LI, and the key members of the project team include lawyers Grace Gao and Willow Liu.
According to public information, EDDA Technology is a pioneer and leader in the field of intelligent surgical robots and intelligent robotic solutions for precision surgery, which innovates, develops and leads the market in China and abroad. Its core technology platform with independent intellectual property rights empowers and provides support for a series of products and services, with intelligent surgical robots as the core, providing doctors with overall solutions for precision surgery. Its products and services have been adopted in hundreds of departments of hospitals around the world, including Mayo Clinic in US, Peking Union Medical College Hospital in Beijing, West China Hospital in Sichuan, and Ruijin Hospital in Shanghai.
